JYPC(002198)2021-10-25 16:00Financial Performance - The company's revenue for Q3 2021 was ¥150,494,400.62, representing a 2.20% increase year-over-year, while year-to-date revenue reached ¥402,770,114.43, up 13.30% compared to the same period last year[3]. - Net profit attributable to shareholders for Q3 2021 was ¥308,765.66, a significant decrease of 88.31% year-over-year, while year-to-date net profit was ¥4,494,564.57, showing a remarkable increase of 1,875.08%[3]. - The basic and diluted earnings per share for Q3 2021 were both ¥0.0006, down 88.31% year-over-year, while year-to-date earnings per share increased by 1,875.08% to ¥0.0089[4]. - Total operating revenue for Q3 2021 reached CNY 402,770,114.43, an increase of 13.3% compared to CNY 355,499,946.98 in the same period last year[21]. - Net profit for Q3 2021 was CNY 4,494,564.57, a significant recovery from a net loss of CNY 253,203.23 in Q3 2020[22]. - Operating costs for Q3 2021 amounted to CNY 388,343,405.90, up from CNY 351,233,965.81 in the previous year, reflecting a rise of 10.6%[21]. - The company reported a total profit of CNY 8,899,406.31 for Q3 2021, compared to CNY 2,057,481.68 in Q3 2020, indicating a substantial increase[22]. Assets and Liabilities - The company's total assets at the end of Q3 2021 were ¥824,796,596.52, a 2.02% increase from the end of the previous year[4]. - The total liabilities increased to CNY 137,295,990.89 from CNY 125,433,767.07, marking a rise of 9.5%[20]. - The company's total equity increased to CNY 687,500,605.63 from CNY 683,006,041.06, showing a growth of 0.7%[20]. - Total assets as of September 30, 2021, amounted to ¥824,796,596.52, up from ¥808,439,808.13 at the end of 2020, indicating a growth of 2.0%[18]. Cash Flow - Cash flow from operating activities for the year-to-date period was ¥23,481,235.90, reflecting a decrease of 26.16% compared to the same period last year[4]. - The net cash flow from operating activities was CNY 23,481,235.90, a decrease of 26.2% compared to CNY 31,801,926.85 in the previous year[26]. - The net cash flow from investing activities was CNY 31,404,544.11, an increase of 171.5% from CNY 11,589,858.19 in the same period last year[26]. - The net cash flow from financing activities was CNY 15,441,057.25, compared to a negative cash flow of CNY 23,192,093.41 in the previous year, indicating a significant improvement[26]. - The total cash and cash equivalents increased by CNY 70,326,837.26, compared to an increase of CNY 20,199,691.63 in the same quarter last year[26]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 28,722[12]. - The top 10 shareholders hold a combined 56.77% of shares, with Shenzhen Tiger Fund Management Co., Ltd. holding 11.27% (57,200,000 shares) and Chen Yonghong holding 10.01% (50,778,500 shares)[12]. - The top 10 shareholders involved in margin trading hold a total of 6,865,753 shares through Citic Securities and 5,030,000 shares through Caitong Securities[12]. Operational Highlights - The company experienced a 313.79% increase in other operating income year-over-year, primarily due to increased government subsidies[9]. - Cash received from investment recoveries increased by ¥14,000,000, a 75.68% increase year-over-year, due to the recovery of funds from Guizhou Yun Guiding Technology[10]. - Research and development expenses were CNY 5,753,031.90, slightly increasing from CNY 5,690,694.01 in the same quarter last year[21]. Corporate Actions - The company plans to issue non-public shares to New South Medical, with the proposal approved by the board on June 17, 2021[15]. - The company has terminated the voting rights entrustment agreement with New South Medical, allowing it to exercise its shareholder rights independently[14]. - The company has not disclosed any new product developments or market expansion strategies in the current report[1]. - The company has not received the third-quarter financial report from Guangdong Kangci Medical Management Co., Ltd., leading to an estimated investment loss of ¥2.3 million[15]. Audit and Reporting - The company did not undergo an audit for the third quarter report[28]. - The report was released by the board of directors on October 25, 2021[29].